Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

ElevateBio

Main (gene editing) focus: Novel gene- and cell therapies

Company stage: Clinical

Diseases: Undisclosed

Genome editing tool: CRISPR-Cas, base editing, CRISPRa/CRISPRi

Funding stage: Private

Location: Cambridge, MA, USA

Website: https://www.elevate.bio/

Pipeline: https://www.elevate.bio/portfolio-pipeline

Partnerships: Life Edit Therapeutics (acquired)

ElevateBio is a gene- and cell therapy company. It is engaged in the genome-editing field through its acquisition of Life Edit Therapeutics that develops novel CRISPR-Cas, base editing and CRISPRa/CRISPRi systems. The company anticipates to integrate these novel gene-editing technologies with its existing iPSC, viral vector, and cell engineering platforms.

Tags

HashtagElevateBio

Company: ElevateBio
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine